Metabolite of oxazaphosphorine drug

Metabolites of oxazaphosphorine drugs" is not a specific molecular entity or target, but rather refers broadly to the various biochemical products generated by the metabolic transformation of oxazaphosphorine class prodrugs—including cyclophosphamide, ifosfamide, and trofosfamide—in the body[1][2][5][7]. These metabolites arise through cytochrome P450-dependent bioactivation and can be subdivided into those with therapeutic activity (such as phosphoramide mustard, ifosforamide mustard) that alkylate DNA to exert cytotoxic action, and those with toxic side effects (such as acrolein or chloroacetaldehyde) that contribute to drug toxicity[1][2][5]. Because the term denotes a heterogeneous group of structurally- and functionally-distinct compounds rather than a specific molecule, receptor, enzyme, or other canonical drug target, it is not correct to list "metabolites of oxazaphosphorine drugs" as a unique therapeutic target. The metabolism, activities, and toxicity of individual metabolites depend on enzymatic pathways including cytochrome P450, aldehyde dehydrogenases, and glutathione-S-transferases[1][5]. Therefore, the term is too broad and nonspecific to serve as a canonical therapeutic target.

Other names

Oxazaphosphorine metaboliteActive metabolite of oxazaphosphorineOxazaphosphorine drug metabolite

DNA alkylation (for active metabolites such as phosphoramide mustard or ifosforamide mustard); DNA damage induction